Puma Biotechnology (PBYI) Operating Margin (2017 - 2026)
Puma Biotechnology (PBYI) operating margin from Sep 30, 2017 to Mar 31, 2026. The current Puma Biotechnology (PBYI) operating margin is -8.55%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of Puma Biotechnology (PBYI)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | 16.33% | +21.55% |
| 2024 | 13.44% | -2.99% |
| 2023 | 13.85% | +33.16% |
| 2022 | 10.40% | +1941.40% |
| 2021 | 0.51% | -103.77% |
| 2020 | -13.50% | -5.82% |
| 2019 | -14.34% | N/A |
| 2019 | 0.00% | N/A |
| 2019 | 0.00% | N/A |
| 2019 | 0.00% | -100.00% |
| 2018 | -37.71% | N/A |
| 2018 | 0.00% | N/A |
| 2018 | 0.00% | N/A |
| 2018 | 0.00% | -100.00% |
| 2017 | -1055.94% | N/A |
| 2017 | 0.00% | N/A |
Comparison Puma Biotechnology (PBYI) operating margin with competitors
Puma Biotechnology (PBYI) operating margin is -8.55%.